FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “BioNTech SE Surges after it and Pfizer Inc. Received Positive CHMP Opinion for Comirnaty in Children ages 5-12”
BioNTech SE (NASDAQ: BNTX) climbed over 10% in premarket trading after the company and Pfizer Inc. received a positive CHMP Opinion on the administration of COMIRNATY® in children 5 to under 12 years of age.
Should the companies’ COVID-19 vaccine COMIRNATY® receive subsequent approval from the European Commission, it will be the first COVID-19 vaccine authorized in the European Union for individuals 5 to under 12 years of age.
Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules.
For more information, please visit: BioNTech SE
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.